What is Enzymatic Therapy?
The use of natural systemic enzymes to destroy cancer cells and decrease tumors in patients is referred to as enzymatic cancer treatment/ therapy. Enzyme replacement therapy is a medical procedure that restores an enzyme in the body that is inadequate or missing. The patient is usually given an intravenous (IV) infusion of an enzyme solution.
What does clinical research say about Enzyme Therapy?
While research on enzyme treatment is still ongoing, preliminary findings suggest that enzymes may impact cancer growth. For example, PEG-KYNase is an enzyme that degrades kynurenine, a chemical generated by tumor cells that inhibits the immune system. While PEG-KYNase may not kill cancer cells directly, it may help the immune system attack cancer cells and slow their proliferation.
Other research suggests that different enzymes such as (alkaline phosphatase, beta-glucosidases, and others) can be used to kill cancer cells directly.
Using novel techniques, these enzymes could be delivered directly into cancer cells, causing significant damage and ultimately cancer cell death.
What is known about Systemic Enzyme Therapy?
Another type of enzyme therapy is systemic enzyme therapy, which uses high dosages of enzymes to break down tumor cells while also promoting immune function by removing dangerous germs. Systemic enzyme treatment, as opposed to pancreatic enzyme replacement therapy (PERT), helps to increase the effectiveness of other therapies by targeting malignant cells and enhancing enzyme activity in the body.
How is Enzymatic Cancer Therapy administered?
The particular enzymes to be utilized, as well as the proper treatment dosage and administration of enzymatic cancer therapy, may be determined by the patient’s health and personal needs, as well as the severity and stage of the disease. Injecting enzymes into cancer cells could kill the cells, slow their growth, and reduce tumors.
How is Enzyme Therapy for Pancreatic Cancer Patients?
Pancreatic cancer (PC) is one of the top 10 cancers that kill people worldwide. Many patients lose weight as a result of malnutrition caused by this condition. Intrinsic (tumor cell-triggered) and extrinsic (host-triggered) variables are the major causes of malnutrition. As a result, patients with pancreatic cancer may develop pancreatic exocrine insufficiency (PEI). This condition can be addressed with pancreatic enzyme replacement therapy (PERT). PERT is available in the form of digestive enzymes or oral enzyme supplements that patients can take with food. Patients who receive PERT treatment can improve their nutritional health and immune function, allowing them to pursue other treatments to combat malignant cells and stop tumor growth.
What are the side effects of Enzyme Therapy?
Patients may develop digestive problems such as diarrhea, nausea, and vomiting, especially if they take very large doses.
Dr. Gaetano Morello discusses Enzymatic Therapy and a specific type of enzyme called -CF IP-6 & Inositol that can help combat malignant cells and other damaging pollutants in the video below.
